Collectively, these findings underscored that bioactive compounds derived from TCM counteract AP pathogenesis by targeting inflammatory pathways, including NF-κB, MAPK, and NLRP3 inflammasome. This evidence concerns the gene NFKB1 and alkaline phosphatase measurement.